MECASERMIN

MECASERMIN was reported 812 times

MECASERMIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRIPLE A SYNDROME 1 0.3333
1 TESTICULAR APPENDAGE TORSION 2 0.3333
2 INTESTINAL NEURONAL DYSPLASIA 1 0.2500
3 OSTEOFIBROMA 1 0.1429
4 SPONDYLECTOMY 1 0.1111
5 SECRETORY ADENOMA OF PITUITARY 1 0.0909
6 AURAL POLYP 5 0.0758
7 CAECUM OPERATION 1 0.0714
8 OVARIAN GRANULOSA-THECA CELL TUMOUR 2 0.0571
9 RATHKE'S CLEFT CYST 1 0.0500
10 CARTILAGE HYPERTROPHY 1 0.0500
11 LACTASE DEFICIENCY 1 0.0455
12 CARTILAGE NEOPLASM 1 0.0435
13 MULTIPLE ENDOCRINE NEOPLASIA 1 0.0435
14 IMPLANT SITE PAPULES 1 0.0417
15 KWASHIORKOR 1 0.0417
16 ANDROPAUSE 2 0.0385
17 PAEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDERS ASSOCIATED WITH STREPTOCOCCAL INFECTION 1 0.0385
18 RADIOALLERGOSORBENT TEST POSITIVE 1 0.0357
19 SPLENIC VARICES 1 0.0345
20 ADENOIDAL HYPERTROPHY 12 0.0317
21 OPTIC DISCS BLURRED 2 0.0312
22 EYEGLASSES THERAPY 1 0.0312
23 INSULIN RESISTANCE SYNDROME 1 0.0303
24 BILATERAL BREAST BUDS 1 0.0294
25 ACTH STIMULATION TEST ABNORMAL 1 0.0286
26 INFERIORITY COMPLEX 1 0.0270
27 OVARIAN GRANULOSA CELL TUMOUR 2 0.0267
28 STERNOTOMY 1 0.0244
29 TONSILLAR HYPERTROPHY 36 0.0214
30 TESTICULAR TORSION 3 0.0207
31 DYSPLASTIC NAEVUS SYNDROME 1 0.0204
32 PERFORMANCE ENHANCING PRODUCT USE 2 0.0202
33 DIABETES MELLITUS MANAGEMENT 1 0.0196
34 AUTOSOMAL CHROMOSOME ANOMALY 1 0.0182
35 BRAIN EMPYEMA 1 0.0179
36 CSF VOLUME INCREASED 2 0.0168
37 EPIPHYSIOLYSIS 4 0.0161
38 POSTPRANDIAL HYPOGLYCAEMIA 3 0.0160
39 ENCOPRESIS 3 0.0155
40 VOLVULUS OF SMALL BOWEL 3 0.0152
41 TYMPANIC MEMBRANE HYPERAEMIA 1 0.0141
42 ECHINOCOCCIASIS 1 0.0137
43 CSF WHITE BLOOD CELL COUNT POSITIVE 1 0.0135
44 OVARIAN TORSION 1 0.0120
45 ADENOTONSILLECTOMY 3 0.0120
46 OESOPHAGOGASTRIC FUNDOPLASTY 2 0.0118
47 NASAL TURBINATE HYPERTROPHY 4 0.0106
48 EXCESSIVE EXERCISE 1 0.0105
49 RETINOPATHY PROLIFERATIVE 2 0.0103
50 MANUFACTURING PRODUCTION ISSUE 1 0.0096
51 ACROMEGALY 3 0.0095
52 KARYOTYPE ANALYSIS ABNORMAL 1 0.0092
53 TONGUE BLACK HAIRY 1 0.0084
54 BLOOD GROWTH HORMONE ABNORMAL 1 0.0082
55 LIPOHYPERTROPHY 5 0.0080
56 NEUTRALISING ANTIBODIES 1 0.0079
57 GASTRITIS VIRAL 1 0.0076
58 GROWING PAINS 2 0.0074
59 CARDIAC VENTRICULAR DISORDER 3 0.0073
60 BENIGN INTRACRANIAL HYPERTENSION 9 0.0072
61 OTITIS MEDIA CHRONIC 3 0.0071
62 ADENOMATOUS POLYPOSIS COLI 1 0.0071
63 CYSTIC LUNG DISEASE 1 0.0070
64 CONGENITAL NAEVUS 1 0.0070
65 HETEROPHORIA 1 0.0069
66 MALOCCLUSION 2 0.0068
67 BONE LESION EXCISION 1 0.0066
68 EPIPHYSES PREMATURE FUSION 2 0.0066
69 ANOREXIA NERVOSA 2 0.0062
70 ENLARGED CLITORIS 1 0.0061
71 OVARIAN ADENOMA 1 0.0060
72 SPIDER NAEVUS 1 0.0054
73 ACANTHOSIS NIGRICANS 1 0.0054
74 NOSE DEFORMITY 2 0.0054
75 BLOOD KETONE BODY PRESENT 1 0.0053
76 SIGHT DISABILITY 1 0.0053
77 PRECOCIOUS PUBERTY 3 0.0053
78 OSTEOCHONDROSIS 6 0.0052
79 ADENOIDECTOMY 2 0.0052
80 INSULIN-LIKE GROWTH FACTOR INCREASED 7 0.0049
81 BIRTH MARK 1 0.0048
82 DEVICE EXTRUSION 1 0.0047
83 GROWTH ACCELERATED 1 0.0046
84 HYPERSPLENISM 2 0.0040
85 CHEST WALL HAEMATOMA 1 0.0039
86 ADENOIDAL DISORDER 1 0.0038
87 OVERGROWTH BACTERIAL 1 0.0037
88 LIMB TRAUMATIC AMPUTATION 1 0.0037
89 HYPERTROPHY 2 0.0037
90 VAGINAL ABSCESS 1 0.0037
91 URETERIC DILATATION 1 0.0036
92 PAPILLOEDEMA 16 0.0035
93 BONE DEVELOPMENT ABNORMAL 1 0.0035
94 REFRACTION DISORDER 1 0.0034
95 LACK OF ADMINISTRATION SITE ROTATION 1 0.0033
96 APOPTOSIS 1 0.0032
97 INCREASED DOSE ADMINISTERED 1 0.0032
98 SNORING 12 0.0032
99 ADNEXAL TORSION 1 0.0032
100 CONDUCTIVE DEAFNESS 1 0.0031
101 TYMPANIC MEMBRANE DISORDER 1 0.0031
102 INJECTION SITE HYPERTROPHY 1 0.0031
103 SECONDARY HYPOGONADISM 1 0.0030
104 CHRONIC MYELOMONOCYTIC LEUKAEMIA 2 0.0030
105 ABDOMINOPLASTY 1 0.0030
106 GROWTH FAILURE 1 0.0029
107 LIGAMENT OPERATION 1 0.0029
108 MUSCLE HYPERTROPHY 1 0.0028
109 LYMPHOID TISSUE HYPERPLASIA 1 0.0028
110 TOXOPLASMOSIS 3 0.0028
111 COMPLICATIONS OF BONE MARROW TRANSPLANT 1 0.0028
112 DIET NONCOMPLIANCE 1 0.0027
113 GROWTH RETARDATION 8 0.0027
114 ENTEROBACTER SEPSIS 1 0.0027
115 BODY DYSMORPHIC DISORDER 1 0.0027
116 OVARIAN ENLARGEMENT 1 0.0026
117 LIMB ASYMMETRY 2 0.0026
118 LOW SET EARS 1 0.0024
119 VULVAL ABSCESS 1 0.0024
120 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0024
121 IDIOPATHIC INTRACRANIAL HYPERTENSION 5 0.0022
122 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0022
123 INTRACRANIAL PRESSURE INCREASED 12 0.0022
124 EATING DISORDER SYMPTOM 1 0.0022
125 SHOCK HYPOGLYCAEMIC 1 0.0021
126 OPEN FRACTURE 1 0.0021
127 DRUG ADMINISTERED IN WRONG DEVICE 2 0.0020
128 POLYCYSTIC OVARIES 3 0.0019
129 DEVICE USE CONFUSION 1 0.0019
130 INSULIN-LIKE GROWTH FACTOR DECREASED 1 0.0019
131 HYDROCELE 2 0.0019
132 OTITIS MEDIA 6 0.0018
133 BLOOD INSULIN INCREASED 1 0.0018
134 VISUAL ACUITY TESTS ABNORMAL 1 0.0018
135 BLOOD GROWTH HORMONE INCREASED 1 0.0018
136 BUNION OPERATION 1 0.0018
137 SOFT TISSUE SWELLING 1 0.0018
138 METAL POISONING 1 0.0017
139 AMBLYOPIA 1 0.0017
140 GINGIVAL HYPERPLASIA 1 0.0017
141 ESCHERICHIA TEST POSITIVE 2 0.0017
142 FEBRILE CONVULSION 2 0.0016
143 OTITIS EXTERNA 2 0.0016
144 ENDOMETRIAL ADENOCARCINOMA 1 0.0016
145 THYROXINE FREE INCREASED 1 0.0016
146 SICKLE CELL ANAEMIA 1 0.0016
147 PROCEDURAL VOMITING 1 0.0015
148 BODY MASS INDEX INCREASED 2 0.0015
149 INJECTION SITE MACULE 1 0.0015
150 CULTURE URINE POSITIVE 2 0.0014
151 BLOOD TESTOSTERONE INCREASED 3 0.0014
152 MELANOCYTIC NAEVUS 6 0.0014
153 HYPERTROPHIC CARDIOMYOPATHY 2 0.0013
154 HYPOGLYCAEMIA 62 0.0013
155 DYSMORPHISM 3 0.0013
156 VOLVULUS 3 0.0013
157 OPTIC NERVE DISORDER 2 0.0012
158 SPINAL FUSION SURGERY 5 0.0012
159 BREATH ODOUR 3 0.0012
160 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
161 IGA NEPHROPATHY 2 0.0012
162 TONSILLECTOMY 2 0.0012
163 PYLORIC STENOSIS 1 0.0012
164 ADENOMA BENIGN 1 0.0012
165 TESTICULAR ATROPHY 1 0.0011
166 SPLENIC INFARCTION 2 0.0011
167 AXONAL NEUROPATHY 1 0.0011
168 SCOLIOSIS 7 0.0011
169 HYPERPLASIA 1 0.0011
170 NASAL OEDEMA 2 0.0011
171 HYPOGLYCAEMIC SEIZURE 1 0.0011
172 SELECTIVE EATING DISORDER 1 0.0011
173 FIBROMA 1 0.0011
174 MUSCLE SWELLING 1 0.0011
175 PHARYNGEAL HYPOAESTHESIA 1 0.0011
176 SKIN TEST POSITIVE 1 0.0011
177 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
178 HYPERMETROPIA 1 0.0011
179 FACIAL ASYMMETRY 1 0.0010
180 ULNA FRACTURE 1 0.0010
181 PHARYNGEAL ERYTHEMA 2 0.0009
182 FACIAL PALSY 2 0.0009
183 KETOSIS 1 0.0009
184 PNEUMONIA STREPTOCOCCAL 1 0.0009
185 SOFT TISSUE DISORDER 1 0.0009
186 AORTIC DILATATION 1 0.0009
187 COMPLEX PARTIAL SEIZURES 1 0.0009
188 CARDIAC HYPERTROPHY 1 0.0009
189 TONSILLAR DISORDER 1 0.0009
190 VITH NERVE PARALYSIS 1 0.0009
191 T-CELL LYMPHOMA 1 0.0009
192 CEREBRAL VENTRICLE DILATATION 1 0.0009
193 EPIDIDYMITIS 1 0.0009
194 LIP ULCERATION 1 0.0009
195 INJECTION SITE URTICARIA 21 0.0009
196 DYSPLASIA 1 0.0008
197 RADIUS FRACTURE 2 0.0008
198 PHARYNGITIS STREPTOCOCCAL 9 0.0008
199 HAIR TEXTURE ABNORMAL 11 0.0008
200 LIP DISCOLOURATION 1 0.0008
201 HEPATIC INFECTION 1 0.0008
202 ADNEXA UTERI PAIN 1 0.0008
203 ENDOCRINE DISORDER 1 0.0008
204 RHINOVIRUS INFECTION 3 0.0008
205 PROTEIN TOTAL ABNORMAL 1 0.0008
206 HYPOVITAMINOSIS 1 0.0008
207 BLOOD GLUCOSE DECREASED 36 0.0007
208 JAW DISORDER 4 0.0007
209 EOSINOPHILIC OESOPHAGITIS 2 0.0007
210 THERAPEUTIC PROCEDURE 1 0.0007
211 STRABISMUS 2 0.0007
212 GINGIVAL HYPERTROPHY 1 0.0007
213 CALCULUS URINARY 1 0.0006
214 INJECTION SITE HYPERSENSITIVITY 2 0.0006
215 PITUITARY TUMOUR BENIGN 1 0.0006
216 INJECTION SITE ATROPHY 1 0.0006
217 INJECTION RELATED REACTION 1 0.0006
218 EXPIRED DRUG ADMINISTERED 3 0.0006
219 PEPTIC ULCER 2 0.0006
220 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
221 SPLEEN DISORDER 1 0.0006
222 GAZE PALSY 1 0.0006
223 PAPILLARY THYROID CANCER 1 0.0006
224 MITRAL VALVE DISEASE 1 0.0006
225 INDURATION 1 0.0006
226 AORTIC VALVE STENOSIS 1 0.0006
227 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0006
228 LYMPH NODE PAIN 1 0.0005
229 BLOOD CHOLESTEROL DECREASED 1 0.0005
230 BONE MARROW TRANSPLANT 1 0.0005
231 SLEEP APNOEA SYNDROME 10 0.0005
232 RETINAL OEDEMA 1 0.0005
233 NASAL SEPTUM DEVIATION 1 0.0005
234 HYPOGLYCAEMIC UNCONSCIOUSNESS 1 0.0005
235 CEREBRAL ATROPHY 2 0.0005
236 GOITRE 2 0.0005
237 SELF-MEDICATION 2 0.0005
238 SKIN INDURATION 1 0.0005
239 INSULIN RESISTANCE 1 0.0005
240 NEUROGENIC BLADDER 1 0.0005
241 INCREASED APPETITE 9 0.0005
242 SCREAMING 3 0.0005
243 FACIAL PARALYSIS 4 0.0005
244 INJECTION SITE INDURATION 6 0.0005
245 MIDDLE EAR EFFUSION 1 0.0005
246 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
247 BACTERIAL TEST POSITIVE 1 0.0004
248 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
249 EYELID OEDEMA 5 0.0004
250 SPINAL COLUMN STENOSIS 2 0.0004
251 WEIGHT ABNORMAL 1 0.0004
252 GASTROINTESTINAL OBSTRUCTION 1 0.0004
253 STARING 1 0.0004
254 VENTRICULAR HYPERTROPHY 1 0.0004
255 OSTEITIS 1 0.0004
256 EXCORIATION 1 0.0004
257 DIABETIC COMPLICATION 1 0.0004
258 HEPATOSPLENOMEGALY 1 0.0004
259 TONSILLITIS 2 0.0004
260 PERSONALITY DISORDER 1 0.0004
261 NASAL DISORDER 1 0.0004
262 ANIMAL BITE 1 0.0004
263 INJECTION SITE PRURITUS 25 0.0004
264 BRUXISM 2 0.0004
265 BLOOD SODIUM INCREASED 1 0.0004
266 CLONUS 1 0.0004
267 RED BLOOD CELL COUNT INCREASED 1 0.0004
268 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
269 VITREOUS HAEMORRHAGE 1 0.0004
270 CYSTIC FIBROSIS 2 0.0004
271 HUNGER 5 0.0004
272 SKIN HYPERTROPHY 1 0.0004
273 GENERALISED ERYTHEMA 2 0.0004
274 PARAPLEGIA 1 0.0003
275 VOMITING PROJECTILE 1 0.0003
276 SOCIAL AVOIDANT BEHAVIOUR 2 0.0003
277 LUMBAR SPINAL STENOSIS 1 0.0003
278 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
279 URINE ANALYSIS ABNORMAL 1 0.0003
280 VIRAL INFECTION 11 0.0003
281 INJECTION SITE VESICLES 2 0.0003
282 DUODENITIS 1 0.0003
283 PORTAL HYPERTENSION 1 0.0003
284 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
285 LIVER ABSCESS 1 0.0003
286 BREAST ENLARGEMENT 1 0.0003
287 DEAFNESS NEUROSENSORY 1 0.0003
288 CRYING 11 0.0003
289 NEPHRITIS 1 0.0003
290 B-CELL LYMPHOMA 1 0.0003
291 REGURGITATION 1 0.0003
292 VIITH NERVE PARALYSIS 1 0.0003
293 EAR PRURITUS 1 0.0003
294 PRODUCT CONTAMINATION 1 0.0003
295 FEAR OF INJECTION 2 0.0003
296 PRODUCT SUPPLY ISSUE 2 0.0003
297 GASTROENTERITIS VIRAL 5 0.0003
298 BLOOD GLUCOSE FLUCTUATION 3 0.0003
299 BLOOD GLUCOSE ABNORMAL 5 0.0003
300 MALNUTRITION 3 0.0003
301 AUTOIMMUNE THYROIDITIS 1 0.0003
302 EAR INFECTION 7 0.0003
303 CLAVICLE FRACTURE 1 0.0003
304 THYROID MASS 1 0.0003
305 SPLENOMEGALY 3 0.0003
306 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
307 INJECTION SITE MASS 9 0.0002
308 GENERALISED OEDEMA 3 0.0002
309 DRUG DOSE OMISSION 40 0.0002
310 INJECTION SITE IRRITATION 3 0.0002
311 AORTIC VALVE INCOMPETENCE 1 0.0002
312 ABSCESS LIMB 1 0.0002
313 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
314 TENSION HEADACHE 1 0.0002
315 TEARFULNESS 1 0.0002
316 HORDEOLUM 1 0.0002
317 IRON DEFICIENCY 1 0.0002
318 PALLOR 6 0.0002
319 EXOSTOSIS 2 0.0002
320 DISEASE COMPLICATION 1 0.0002
321 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
322 RETINAL DETACHMENT 2 0.0002
323 INCREASED TENDENCY TO BRUISE 2 0.0002
324 HEPATIC CIRRHOSIS 4 0.0002
325 SKIN TIGHTNESS 1 0.0002
326 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
327 MYELODYSPLASTIC SYNDROME 3 0.0002
328 HYPERTHYROIDISM 3 0.0002
329 INJECTION SITE HAEMATOMA 3 0.0002
330 GASTROENTERITIS 3 0.0002
331 HORMONE LEVEL ABNORMAL 1 0.0002
332 HYPERNATRAEMIA 1 0.0002
333 PROTEIN URINE PRESENT 1 0.0002
334 INJECTION SITE BRUISING 16 0.0002
335 PRODUCT DOSE OMISSION 13 0.0002
336 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14 0.0002
337 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1 0.0002
338 ENDOCARDITIS 1 0.0002
339 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
340 INJECTION SITE WARMTH 4 0.0002
341 CACHEXIA 1 0.0002
342 TEMPERATURE INTOLERANCE 2 0.0002
343 STOMACH DISCOMFORT 1 0.0002
344 INJECTION SITE ERYTHEMA 24 0.0002
345 PERIORBITAL OEDEMA 1 0.0002
346 RESPIRATORY TRACT INFECTION 5 0.0002
347 MALABSORPTION 1 0.0002
348 SUDDEN DEATH 2 0.0002
349 MOOD SWINGS 6 0.0002
350 IRRITABLE BOWEL SYNDROME 4 0.0002
351 HEREDITARY ANGIOEDEMA 2 0.0002
352 HYDROCEPHALUS 1 0.0002
353 TIC 1 0.0002
354 INJECTION SITE SWELLING 14 0.0002
355 OSTEONECROSIS 6 0.0002
356 VENTRICULAR TACHYCARDIA 3 0.0002
357 FOOT DEFORMITY 2 0.0002
358 LIP SWELLING 6 0.0002
359 STREPTOCOCCAL INFECTION 1 0.0002
360 PERIORBITAL SWELLING 1 0.0002
361 NASAL CONGESTION 10 0.0002
362 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
363 ENERGY INCREASED 1 0.0002
364 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
365 BLOOD IRON DECREASED 2 0.0002
366 BACTERAEMIA 2 0.0002
367 TYPE 1 DIABETES MELLITUS 1 0.0002
368 INJECTION SITE DISCOLOURATION 2 0.0002
369 AGGRESSION 8 0.0002
370 BLEPHAROSPASM 1 0.0002
371 CONVULSION 9 0.0002
372 UNRESPONSIVE TO STIMULI 4 0.0002
373 DIPLOPIA 4 0.0002
374 ANGINA UNSTABLE 1 0.0002
375 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
376 OFF LABEL USE 133 0.0002
377 HAEMATOCRIT DECREASED 3 0.0002
378 APPETITE DISORDER 1 0.0002
379 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
380 SINUS CONGESTION 2 0.0001
381 EYE MOVEMENT DISORDER 1 0.0001
382 RESPIRATORY DISTRESS 4 0.0001
383 ENCEPHALITIS 1 0.0001
384 SKIN REACTION 2 0.0001
385 HAND FRACTURE 1 0.0001
386 GRAFT VERSUS HOST DISEASE 1 0.0001
387 PRURITUS GENERALISED 3 0.0001
388 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
389 NEEDLE ISSUE 4 0.0001
390 HYPERGLYCAEMIA 5 0.0001
391 ANGIOEDEMA 6 0.0001
392 PSYCHIATRIC SYMPTOM 1 0.0001
393 CARDIOMYOPATHY 2 0.0001
394 ARTHROPOD BITE 1 0.0001
395 EYE SWELLING 5 0.0001
396 INJECTION SITE PAIN 41 0.0001
397 CHROMATURIA 3 0.0001
398 TENDON PAIN 1 0.0001
399 HAEMODYNAMIC INSTABILITY 1 0.0001
400 PROCEDURAL COMPLICATION 1 0.0001
401 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
402 INJECTION SITE RASH 4 0.0001
403 DEVICE RELATED INFECTION 2 0.0001
404 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
405 EMOTIONAL DISORDER 4 0.0001
406 LYMPHOMA 2 0.0001
407 CONGENITAL ANOMALY 1 0.0001
408 CONCUSSION 1 0.0001
409 HYPOALBUMINAEMIA 1 0.0001
410 APNOEA 1 0.0001
411 CYANOSIS 2 0.0001
412 RENAL CYST 1 0.0001
413 FRUSTRATION TOLERANCE DECREASED 1 0.0001
414 SWELLING FACE 8 0.0001
415 SUBSTANCE ABUSE 1 0.0001
416 SHOCK HAEMORRHAGIC 1 0.0001
417 HAIR DISORDER 1 0.0001
418 EOSINOPHIL COUNT INCREASED 1 0.0001
419 FACE OEDEMA 2 0.0001
420 HYPOPHAGIA 3 0.0001
421 PSEUDOMONAS INFECTION 1 0.0001
422 CARDIAC OPERATION 1 0.0001
423 DECREASED APPETITE 27 0.0001
424 RASH GENERALISED 3 0.0001
425 MUSCLE STRAIN 1 0.0001
426 PYELONEPHRITIS 1 0.0001
427 SKIN SWELLING 1 0.0001
428 DEAFNESS 3 0.0001
429 URTICARIA 19 0.0001
430 HAEMOLYTIC ANAEMIA 1 0.0001
431 OPTIC NEURITIS 1 0.0001
432 RESTLESS LEGS SYNDROME 2 0.0001
433 ACCIDENTAL OVERDOSE 4 0.0001
434 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
435 OVARIAN CANCER 1 0.0001
436 NERVE COMPRESSION 1 0.0001
437 GRAND MAL CONVULSION 1 0.0001
438 RHINORRHOEA 7 0.0001
439 CONJUNCTIVITIS 2 0.0001
440 PRODUCT DISTRIBUTION ISSUE 1 0.0001
441 PERSONALITY CHANGE 1 0.0001
442 ERYTHEMA MULTIFORME 1 0.0001
443 APPENDICITIS 1 0.0001
444 HEADACHE 67 0.0001
445 FLANK PAIN 1 0.0001
446 LACERATION 1 0.0001
447 LEUKAEMIA 1 0.0001
448 FRACTURE 2 0.0001
449 FOOT FRACTURE 2 0.0001
450 GASTRIC ULCER 2 0.0001
451 FEELING JITTERY 2 0.0001
452 LETHARGY 6 0.0001
453 PYREXIA 36 0.0001
454 AFFECT LABILITY 1 0.0001
455 ATELECTASIS 1 0.0001
456 EAR PAIN 2 0.0001
457 AUTOIMMUNE DISORDER 1 0.0001
458 PRODUCT DOSE OMISSION ISSUE 30 0.0001
459 COELIAC DISEASE 1 0.0001
460 HEPATOMEGALY 1 0.0001
461 LABORATORY TEST ABNORMAL 3 0.0001
462 LIGAMENT SPRAIN 1 0.0001
463 ABNORMAL BEHAVIOUR 4 0.0001
464 UPPER LIMB FRACTURE 2 0.0001
465 HYPOTONIA 1 0.0001
466 IRRITABILITY 6 0.0001
467 BRAIN INJURY 1 0.0001
468 VAGINAL DISCHARGE 1 0.0001
469 FEEDING DISORDER 2 0.0001
470 EYELID PTOSIS 1 0.0001
471 DRUG ADMINISTRATION ERROR 3 0.0001
472 GYNAECOMASTIA 3 0.0001
473 ABDOMINAL DISTENSION 10 0.0001
474 INJECTION SITE DISCOMFORT 1 0.0001
475 JOINT DISLOCATION 1 0.0001
476 DEPRESSED MOOD 5 0.0001
477 EATING DISORDER 2 0.0001
478 RETCHING 2 0.0001
479 VOMITING 44 0.0001
480 POOR QUALITY SLEEP 2 0.0001
481 DECREASED ACTIVITY 1 0.0001
482 PRODUCT PRESCRIBING ISSUE 2 0.0001
483 OESOPHAGITIS 1 0.0001
484 TREATMENT NONCOMPLIANCE 5 0.0001
485 ASPIRATION 1 0.0001
486 INJECTION SITE NODULE 1 0.0001
487 DENTAL CARIES 1 0.0001
488 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
489 INFLUENZA 10 0.0001
490 SKIN INFECTION 1 0.0001
491 EYE INFECTION 1 0.0001
492 INJECTION SITE HAEMORRHAGE 7 0.0001
493 MICTURITION URGENCY 1 0.0001
494 MYOCARDITIS 1 0.0001
495 SKIN DISCOLOURATION 4 0.0001
496 ELECTROLYTE IMBALANCE 1 0.0001
497 POST PROCEDURAL HAEMORRHAGE 1 0.0001
498 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
499 ACCIDENT 1 0.0001
500 WRIST FRACTURE 1 0.0001
501 SPINAL OPERATION 1 0.0001
502 INJECTION SITE EXTRAVASATION 1 0.0001
503 PHARYNGITIS 1 0.0001
504 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
505 HAIR COLOUR CHANGES 1 0.0001
506 MUSCLE ATROPHY 1 0.0001
507 HEPATITIS 2 0.0001
508 HYPERHIDROSIS 10 0.0001
509 INCORRECT PRODUCT STORAGE 1 0.0001
510 IMMUNE SYSTEM DISORDER 1 0.0001
511 MALIGNANT MELANOMA 1 0.0001
512 JOINT RANGE OF MOTION DECREASED 1 0.0001
513 DISTURBANCE IN ATTENTION 4 0.0001
514 GINGIVAL BLEEDING 1 0.0001
515 INJECTION SITE REACTION 5 0.0001
516 NECK PAIN 4 0.0001
517 MASS 1 0.0001
518 NASOPHARYNGITIS 13 0.0001
519 SUBDURAL HAEMATOMA 1 0.0001
520 HYPOACUSIS 3 0.0001
521 OVERDOSE 15 0.0001
522 SOMNOLENCE 14 0.0001
523 SEIZURE 8 0.0001
524 UNDERDOSE 5 0.0001
525 HAEMOGLOBIN DECREASED 7 0.0001
526 ASCITES 2 0.0001
527 IMMUNODEFICIENCY 1 0.0001
528 RESPIRATORY DISORDER 2 0.0001
529 BLOOD POTASSIUM DECREASED 2 0.0001
530 HEPATIC FAILURE 2 0.0001
531 THERAPEUTIC RESPONSE DECREASED 4 0.0001
532 BLOOD COUNT ABNORMAL 1 0.0001
533 EPILEPSY 2 0.0001
534 NEPHROLITHIASIS 3 0.0001
535 ANKLE FRACTURE 1 0.0001
536 ABDOMINAL PAIN 15 0.0001
537 DRUG-INDUCED LIVER INJURY 2 0.0001
538 SICKLE CELL ANAEMIA WITH CRISIS 1 0.0001
539 ULCER 1 0.0001
540 MIGRAINE 6 0.0001
541 OBESITY 1 0.0001
542 EYE DISORDER 2 0.0001
543 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
544 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
545 DEHYDRATION 8 0.0001
546 CONSTIPATION 13 0.0001
547 EYE PRURITUS 2 0.0001
548 HAEMATURIA 2 0.0001
549 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
550 MULTI-ORGAN FAILURE 1 0.0001
551 NERVOUSNESS 3 0.0001
552 SPEECH DISORDER 3 0.0001
553 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
554 CONDITION AGGRAVATED 17 0.0001
555 LOSS OF CONSCIOUSNESS 7 0.0001
556 TREMOR 9 0.0001
557 BRONCHITIS 4 0.0001
558 HYPERSENSITIVITY 10 0.0001
559 INTESTINAL OBSTRUCTION 2 0.0001
560 DEPRESSION 12 0.0001
561 PULMONARY FIBROSIS 1 0.0001
562 POST PROCEDURAL COMPLICATION 1 0.0001
563 DRUG PRESCRIBING ERROR 1 0.0001
564 GLAUCOMA 1 0.0001
565 HERNIA 1 0.0001
566 ATRIAL FIBRILLATION 5 0.0001
567 ORAL HERPES 1 0.0001
568 BONE PAIN 3 0.0001
569 MALAISE 22 0.0001
570 INTENTIONAL SELF-INJURY 1 0.0000
571 OEDEMA PERIPHERAL 6 0.0000
572 BONE MARROW FAILURE 1 0.0000
573 INJURY ASSOCIATED WITH DEVICE 1 0.0000
574 NEUTROPHIL COUNT DECREASED 2 0.0000
575 BODY TEMPERATURE INCREASED 1 0.0000
576 SINUSITIS 5 0.0000
577 ILLNESS 5 0.0000
578 DERMATITIS 1 0.0000
579 MOUTH ULCERATION 1 0.0000
580 PNEUMONIA 15 0.0000
581 INTENTIONAL PRODUCT MISUSE 4 0.0000
582 LIVER DISORDER 2 0.0000
583 HEPATOTOXICITY 1 0.0000
584 SEPSIS 5 0.0000
585 SNEEZING 1 0.0000
586 PRODUCT AVAILABILITY ISSUE 1 0.0000
587 ABDOMINAL PAIN UPPER 9 0.0000
588 FATIGUE 34 0.0000
589 PERICARDIAL EFFUSION 1 0.0000
590 COUGH 12 0.0000
591 DIABETIC KETOACIDOSIS 1 0.0000
592 INTERSTITIAL LUNG DISEASE 2 0.0000
593 NEURALGIA 1 0.0000
594 AGITATION 3 0.0000
595 ALOPECIA 8 0.0000
596 PAIN IN EXTREMITY 12 0.0000
597 ENCEPHALOPATHY 1 0.0000
598 EPISTAXIS 3 0.0000
599 PNEUMONIA ASPIRATION 1 0.0000
600 LEUKOPENIA 2 0.0000
601 ABDOMINAL PAIN LOWER 1 0.0000
602 BACK PAIN 9 0.0000
603 ANXIETY 11 0.0000
604 MUSCULOSKELETAL PAIN 2 0.0000
605 GASTRITIS 1 0.0000
606 CHEST PAIN 7 0.0000
607 PRODUCT USE ISSUE 7 0.0000
608 FEAR 1 0.0000
609 OEDEMA 2 0.0000
610 PNEUMONITIS 1 0.0000
611 MOOD ALTERED 1 0.0000
612 INFLUENZA LIKE ILLNESS 3 0.0000
613 ANAPHYLACTIC REACTION 2 0.0000
614 MEDICATION ERROR 2 0.0000
615 WOUND 1 0.0000
616 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
617 HYPERSOMNIA 1 0.0000
618 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
619 DIZZINESS 17 0.0000
620 PSYCHOTIC DISORDER 1 0.0000
621 FEELING HOT 2 0.0000
622 ADVERSE EVENT 3 0.0000
623 WEIGHT DECREASED 9 0.0000
624 SWELLING 3 0.0000
625 SWOLLEN TONGUE 1 0.0000
626 HEAD INJURY 1 0.0000
627 ARTHRALGIA 13 0.0000
628 WEIGHT INCREASED 7 0.0000
629 INTENTIONAL OVERDOSE 2 0.0000
630 MOVEMENT DISORDER 1 0.0000
631 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
632 EXPIRED PRODUCT ADMINISTERED 1 0.0000
633 SKIN DISORDER 1 0.0000
634 ABDOMINAL DISCOMFORT 5 0.0000
635 ANGER 1 0.0000
636 HEPATIC ENZYME INCREASED 2 0.0000
637 ASTHENIA 11 0.0000
638 FEELING ABNORMAL 7 0.0000
639 MEMORY IMPAIRMENT 4 0.0000
640 NIGHTMARE 1 0.0000
641 HYPOXIA 1 0.0000
642 SLEEP DISORDER 2 0.0000
643 LYMPHADENOPATHY 1 0.0000
644 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
645 NAUSEA 22 0.0000
646 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
647 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
648 RESTLESSNESS 1 0.0000
649 DYSURIA 1 0.0000
650 ASTHMA 3 0.0000
651 HOT FLUSH 2 0.0000
652 BLOOD GLUCOSE INCREASED 5 0.0000
653 MUSCULAR WEAKNESS 3 0.0000
654 COLITIS 1 0.0000
655 ACNE 2 0.0000
656 ANAEMIA 5 0.0000
657 PARAESTHESIA 4 0.0000
658 RASH 11 0.0000
659 CARDIAC FAILURE 2 0.0000
660 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
661 DYSKINESIA 1 0.0000
662 ERYTHEMA 5 0.0000
663 VISUAL IMPAIRMENT 3 0.0000
664 TREATMENT FAILURE 2 0.0000
665 DRUG ABUSE 2 0.0000
666 RHABDOMYOLYSIS 1 0.0000
667 CARDIO-RESPIRATORY ARREST 1 0.0000
668 ROAD TRAFFIC ACCIDENT 1 0.0000
669 MYALGIA 4 0.0000
670 URINARY TRACT INFECTION 4 0.0000
671 MENTAL DISORDER 1 0.0000
672 TACHYCARDIA 2 0.0000
673 GASTROINTESTINAL DISORDER 2 0.0000
674 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
675 ADVERSE DRUG REACTION 2 0.0000
676 VISION BLURRED 3 0.0000
677 SUICIDAL IDEATION 2 0.0000
678 TINNITUS 1 0.0000
679 BLOOD CHOLESTEROL INCREASED 1 0.0000
680 OCULAR HYPERAEMIA 1 0.0000
681 DISEASE RECURRENCE 1 0.0000
682 COMA 1 0.0000
683 PRODUCTIVE COUGH 1 0.0000
684 DRUG INTOLERANCE 2 0.0000
685 LUNG DISORDER 1 0.0000
686 HYPOAESTHESIA 3 0.0000
687 CELLULITIS 1 0.0000
688 FLUID RETENTION 1 0.0000
689 CHEST DISCOMFORT 2 0.0000
690 INFLAMMATION 1 0.0000
691 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
692 ECZEMA 1 0.0000
693 PANCREATITIS 1 0.0000
694 DIARRHOEA 12 0.0000
695 DRUG EFFECT DECREASED 1 0.0000
696 CONFUSIONAL STATE 3 0.0000
697 RASH PRURITIC 1 0.0000
698 PRURITUS 7 0.0000
699 THROMBOCYTOPENIA 2 0.0000
700 EYE PAIN 1 0.0000
701 DYSPNOEA 10 0.0000
702 EYE IRRITATION 1 0.0000
703 DYSPHONIA 1 0.0000
704 CATARACT 1 0.0000
705 DRUG INEFFECTIVE 22 0.0000
706 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
707 ILL-DEFINED DISORDER 1 0.0000
708 DISCOMFORT 1 0.0000
709 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
710 GAIT DISTURBANCE 3 0.0000
711 FEBRILE NEUTROPENIA 1 0.0000
712 DRY SKIN 2 0.0000
713 PRODUCT QUALITY ISSUE 2 0.0000
714 INJURY 1 0.0000
715 HYPERTENSION 3 0.0000
716 RESPIRATORY FAILURE 1 0.0000
717 DYSGEUSIA 1 0.0000
718 UNEVALUABLE EVENT 1 0.0000
719 INCORRECT DOSE ADMINISTERED 3 0.0000
720 PAIN 8 0.0000
721 ARTHRITIS 1 0.0000
722 DRUG INTERACTION 2 0.0000
723 THROMBOSIS 1 0.0000
724 CARDIAC ARREST 1 0.0000
725 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
726 OROPHARYNGEAL PAIN 1 0.0000
727 CARDIAC DISORDER 1 0.0000
728 NEUROPATHY PERIPHERAL 1 0.0000
729 CONTUSION 1 0.0000
730 DYSPEPSIA 1 0.0000
731 HEART RATE INCREASED 1 0.0000
732 SYNCOPE 1 0.0000
733 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
734 PLATELET COUNT DECREASED 1 0.0000
735 FALL 3 0.0000
736 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
737 PALPITATIONS 1 0.0000
738 DISEASE PROGRESSION 1 0.0000
739 DEATH 7 0.0000
740 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
741 RENAL FAILURE 1 0.0000
742 BLOOD PRESSURE INCREASED 1 0.0000
743 HOSPITALISATION 1 0.0000
744 PERIPHERAL SWELLING 1 0.0000
745 COVID-19 1 0.0000
746 MUSCLE SPASMS 1 0.0000
747 HYPOTENSION 1 0.0000
748 INSOMNIA 1 0.0000